| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $670,400 | 1 | 14 |
Sells | $54,851 | 6 | 86 |
| Wambeke David J. | Chief Business Officer | 1 | $670,400 | 0 | $0 | $670,400 |
| Christianson Mark | Business Development Director | 0 | $0 | 6 | $54,851 | $-54,851 |
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals …
Over the last 12 months, insiders at NeuroOne Medical Technologies Corporation have bought $670,400 and sold $54,851 worth of NeuroOne Medical Technologies Corporation stock.
On average, over the past 5 years, insiders at NeuroOne Medical Technologies Corporation have bought $203,070 and sold $57,989 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Wambeke David J. (Chief Business Officer) — $670,400.
The last purchase of 1,000,000 shares for transaction amount of $670,400 was made by Wambeke David J. (Chief Business Officer) on 2026‑03‑01.
| 2026-06-30 | Sale | Christianson Mark | Market Development Director | 10,000 0.1201% | $3.18 | $31,773 | -46.88% | |
| 2026-03-30 | Sale | Christianson Mark | Business Development Director | 15,363 0.031% | $0.74 | $11,369 | -51.12% | |
| 2026-03-13 | Sale | Christianson Mark | Business Development Director | 100 0.0002% | $0.80 | $80 | -40.02% | |
| 2026-03-12 | Sale | Christianson Mark | Business Development Director | 817 0.0016% | $0.80 | $654 | -41.86% | |
| 2026-03-11 | Sale | Christianson Mark | Business Development Director | 2,109 0.0042% | $0.80 | $1,687 | -40.61% | |
| 2026-03-10 | Sale | Christianson Mark | Business Development Director | 11,611 0.0233% | $0.80 | $9,289 | -39.50% | |
| 2026-03-01 | Wambeke David J. | Chief Business Officer | 1M 1.9792% | $0.67 | $670,400 | -24.75% | ||
| 2025-09-05 | Sale | Christianson Mark | Business Development Director | 30,000 0.0561% | $0.74 | $22,203 | -7.98% | |
| 2025-06-04 | Sale | Christianson Mark | Business Development Director | 10,000 0.0193% | $0.58 | $5,804 | +26.32% | |
| 2025-05-22 | Sale | Christianson Mark | Business Development Director | 8,967 0.0182% | $0.62 | $5,586 | +23.24% | |
| 2025-05-21 | Sale | Christianson Mark | Business Development Director | 14 <0.0001% | $0.65 | $9 | +26.32% | |
| 2025-05-20 | Sale | Christianson Mark | Business Development Director | 3,013 0.0064% | $0.66 | $1,976 | +22.25% | |
| 2025-05-19 | Sale | Christianson Mark | Business Development Director | 8,006 0.0162% | $0.67 | $5,330 | +14.86% | |
| 2025-04-04 | Rosa David A | CEO and President | 100,000 0.3411% | $0.50 | $50,000 | +55.79% | ||
| 2025-04-04 | McClurg Ronald W. | Chief Financial Officer | 200,000 0.6821% | $0.50 | $100,000 | +55.79% | ||
| 2024-06-06 | Sale | Christianson Mark | Business Development Director | 2,189 0.0081% | $0.88 | $1,918 | +0.20% | |
| 2024-06-05 | Sale | Christianson Mark | Business Development Director | 25,800 0.0937% | $0.88 | $22,663 | -2.11% | |
| 2023-12-27 | Sale | Christianson Mark | Business Development Director | 31,445 0.1219% | $1.46 | $45,859 | -39.10% | |
| 2023-12-26 | Sale | Christianson Mark | Business Development Director | 6,848 0.0285% | $1.35 | $9,269 | -29.63% | |
| 2023-12-22 | Sale | Christianson Mark | Business Development Director | 1,800 0.0077% | $1.40 | $2,520 | -30.02% |
| Wambeke David J. | Chief Business Officer | 1000000 10.9821% | $980,000.00 | 1 | 0 | |
| Samad Amer | Chief Executive Officer | 3515728 38.6099% | $3.45M | 1 | 0 | |
| Rosa David A | CEO and President | 1161289 12.7533% | $1.14M | 1 | 0 | +55.79% |
| McClurg Ronald W. | Chief Financial Officer | 444117 4.8773% | $435,234.66 | 5 | 0 | +41.38% |
| Volker Christopher | Chief Operating Officer | 75000 0.8237% | $73,500.00 | 1 | 0 | <0.0001% |
| Increased Positions | 17 | +41.46% | 581,712 | +4.03% |
| Decreased Positions | 15 | -36.59% | 3M | -17.68% |
| New Positions | 8 | New | 368,896 | New |
| Sold Out Positions | 6 | Sold Out | 1M | Sold Out |
| Total Postitions | 43 | +4.88% | 12M | -13.65% |
| Bleichroeder Lp | $3,408.00 | 8% | 4M | 0 | 0% | 2025-09-30 |
| Sio Capital Management, Llc | $2,011.00 | 4.72% | 2.36M | -1M | -33.01% | 2025-09-30 |
| Bard Associates Inc | $1,577.00 | 3.7% | 1.85M | -3,600 | -0.19% | 2025-09-30 |
| Vanguard Group Inc | $1,345.00 | 3.16% | 1.58M | +375,639 | +31.24% | 2025-09-30 |
| Perkins Capital Management Inc | $1,251.00 | 2.94% | 1.47M | -32,000 | -2.13% | 2025-09-30 |
| Awm Investment Company, Inc. | $781.00 | 1.83% | 916,667 | 0 | 0% | 2025-09-30 |
| Renaissance Technologies Llc | $590.00 | 1.39% | 692,600 | +223,700 | +47.71% | 2025-09-30 |
| Geode Capital Management, Llc | $423.00 | 0.99% | 496,834 | +148,009 | +42.43% | 2025-09-30 |
| Citadel Advisors Llc | $176.00 | 0.41% | 206,277 | +136,258 | +194.6% | 2025-09-30 |
| Cambridge Investment Research Advisors, Inc. | $103.00 | 0.24% | 121,000 | +40,000 | +49.38% | 2025-09-30 |